These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8814738)

  • 1. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.
    Damato BE; Paul J; Foulds WS
    Br J Ophthalmol; 1996 Feb; 80(2):102-8. PubMed ID: 8814738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for metastatic uveal melanoma after trans-scleral local resection.
    Damato BE; Paul J; Foulds WS
    Br J Ophthalmol; 1996 Feb; 80(2):109-16. PubMed ID: 8814739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local resection of uveal melanoma.
    Damato BE
    Dev Ophthalmol; 2012; 49():66-80. PubMed ID: 22042014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
    van den Bosch T; Vaarwater J; Verdijk R; Muller K; Kiliç E; Paridaens D; de Klein A; Naus N
    Acta Ophthalmol; 2015 Sep; 93(6):555-60. PubMed ID: 25879399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of visual outcome after local resection of choroidal melanoma.
    Damato BE; Paul J; Foulds WS
    Br J Ophthalmol; 1993 Oct; 77(10):616-23. PubMed ID: 8218028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoresection of choroidal melanoma.
    Damato B; Groenewald C; McGalliard J; Wong D
    Br J Ophthalmol; 1998 Mar; 82(3):213-8. PubMed ID: 9602614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
    Puusaari I; Damato B; Kivelä T
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
    Correa ZM; Huth B; Augsburger JJ
    Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate.
    Bechrakis NE; Petousis V; Willerding G; Krause L; Wachtlin J; Stroux A; Foerster MH
    Br J Ophthalmol; 2010 Apr; 94(4):460-6. PubMed ID: 19965818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection.
    Kim JW; Damato BE; Hiscott P
    Arch Ophthalmol; 2002 Dec; 120(12):1659-64. PubMed ID: 12470139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool.
    Wright PK; Damato BE
    J R Coll Surg Edinb; 1999 Aug; 44(4):260-4. PubMed ID: 10453150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleral patch grafts in the management of uveal and ocular surface tumors.
    Barman M; Finger PT; Milman T
    Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveal melanoma: management and outcome of patients with extraocular spread.
    Bellmann C; Lumbroso-Le Rouic L; Levy C; Plancher C; Dendale R; Sastre-Garau X; Asselain B; Desjardins L
    Br J Ophthalmol; 2010 May; 94(5):569-74. PubMed ID: 19965816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.